Antiseizure medication choice in diffuse glioma: A single‐center population‐based experience
Abstract Objective Several antiseizure medications (ASMs) can be considered as first‐line treatment for glioma‐associated epilepsy (GAE). We aimed to find out, if there are subgroups of glioma patients which may benefit from different first‐line ASMs. Methods All diffuse glioma (grade 2–4) patients,...
Saved in:
| Main Authors: | Leena Ollila, Reina Roivainen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Epilepsia Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/epi4.70007 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiseizure medications for primary and secondary seizure prevention after stroke
by: Zoe C. Wolcott, et al.
Published: (2025-07-01) -
Multicentric study of adherence to antiseizure medications among adults with epilepsy attended in neurology departments in Burkina Faso
by: Alfred Anselme Dabilgou, et al.
Published: (2025-02-01) -
Role of pharmacogenomics for prevention of hypersensitivity reactions induced by aromatic antiseizure medications
by: Angel T. Alvarado, et al.
Published: (2025-08-01) -
Are Newer Antiseizure Medications Better Off in Maintaining Oral Health in Persons with Epilepsy?
by: Jayakumari Nandana, et al.
Published: (2025-03-01) -
Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice
by: Michela De Bellis, et al.
Published: (2025-07-01)